Eton Pharmaceuticals, Inc. (ETON) Cash flow
Market cap
$1.6B
P/E ratio
| 2018/12 | 2019/12 | 2020/12 | 2021/12 | 2022/12 | 2023/12 | 2024/12 | |
| Stock-based compensation | 2 | 2 | 3 | 3 | 4 | 3 | 3 |
| Cash from operations | -8 | -18 | -22 | -5 | 5 | 7 | 1 |
| Capital expenditures | -0 | -1 | -0 | -0 | -0 | - | -0 |
| Cash from investing | - | -2 | -0 | -3 | -3 | -1 | -40 |
| Proceeds from issuance of term debt, net | - | 5 | 2 | - | - | - | 25 |
| Repayments of term debt | - | - | - | - | - | - | 1 |
| Cash from financing | 22 | 5 | 32 | 0 | -0 | -1 | 33 |
| Free cash flow | - | ||||||
| FCF margin (%) | - | - |